Halozyme To Receive $10 Million Milestone Payment From Janssen 

The milestone payment is associated with the first commercial sale in the European Union of Janssen's #subcutaneous formulation of DARZALEX® (#daratumumab) #Faspro

@Genmab $GMAB $HALO $JNJ

https://t.co/BMzvWi11YQ